⌘K

Login Start Free

Home/Filings/4/0001610717-23-000041

4//SEC Filing

Grais Linda 4

Accession 0001610717-23-000041

CIK 0001626971other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:54 PM ET

Size

4.2 KB

Accession

0001610717-23-000041

Insider Transaction Report

Form 4

Period: 2023-05-15

Corvus Pharmaceuticals, Inc.CRVS

Director

Transactions

Purchase
Common Stock
2023-05-15$2.45/sh+10,000$24,500→ 10,000 total

Documents

1 file

4
form4.xmlPrimary

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1

filerCIK 0001413306

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 4:54 PM ET
Size: 4.2 KB

View on SEC.gov